James M. Demesa is Director at ONCOSEC MEDICAL Inc (ONCS). They have made 1 open-market trade across 1 company since 2018, most recently 2018-12-17.
CIK 0001511974
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $7K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONCS | 22,501 | $6K |
Shares reported on the most recent Form 4, priced at the 2018-12-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONCS | BUY | 2018-11-07 | 2018-11-26 | $0.82 | $7K | -13.3% | -34.9% | -39.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.